Answers are grounded in this paper and cite their sources.
. High resolution X-ray crystal structures reveal closely related binding modes for both inhibitors to KPC-2, with differences apparent only in positioning of the endocyclic boronate ester oxygen. The results indicate the bicyclic boronate scaffold as both an efficient, long-lasting, KPC-2 inhibitor and capable of supporting further iterations that may improve potency against specific enzyme targets and pre-empt the emergence of inhibitor resistant KPC-2 variants.
No takes yet. Share an insight, caveat, or question.
Tooke et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: